drugset / Trial / NCT01458639
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
Non-randomizedCrossoverSingle-blindDiagnostic
Summary
Phase 3 within-subject trial of Technegas V/Q SPECT and Tc-99m macro-aggregated albumin (MAA) imaging compared to Xenon-133 V/Q planar and Tc-99m macroaggregate of albumin (MAA) imaging for the diagnosis of Pulmonary Embolism (PE).
Timeline
- Start
- 2012-08
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Technegas | Diagnostic / imaging agent | 40.7 mbq | — |
| Comparator | Xenon-133 | Diagnostic / imaging agent | — | — |
| Background | Technetium 99m MAA | Unknown | — | — |